Year |
Citation |
Score |
2023 |
Ramisetty SK, Garg P, Mohanty A, Mirzapoiazova T, Yue E, Wang E, Horne D, Awasthi S, Kulkarni P, Salgia R, Singhal SS. Regression of ovarian cancer xenografts by depleting or inhibiting RLIP. Biochemical Pharmacology. 217: 115847. PMID 37804871 DOI: 10.1016/j.bcp.2023.115847 |
0.758 |
|
2023 |
Garg P, Awasthi S, Horne D, Salgia R, Singhal SS. The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action. Biochimica Et Biophysica Acta. Reviews On Cancer. 188929. PMID 37286146 DOI: 10.1016/j.bbcan.2023.188929 |
0.728 |
|
2023 |
Garg P, Garg R, Horne D, Awasthi S, Salgia R, Singhal SS. Prognostic significance of natural products against multidrug tumor resistance. Cancer Letters. 557: 216079. PMID 36736532 DOI: 10.1016/j.canlet.2023.216079 |
0.719 |
|
2022 |
Singhal SS, Garg R, Horne D, Singhal S, Awasthi S, Salgia R. RLIP: A necessary transporter protein for translating oxidative stress into pro-obesity and pro-carcinogenic signaling. Biochimica Et Biophysica Acta. Reviews On Cancer. 188803. PMID 36150564 DOI: 10.1016/j.bbcan.2022.188803 |
0.748 |
|
2022 |
Nagaprashantha LD, Singhal J, Li H, Warden C, Liu X, Horne D, Awasthi S, Salgia R, Singhal SS. Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer. Oncotarget. 13: 331. PMID 35261722 DOI: 10.18632/oncotarget.28199 |
0.726 |
|
2021 |
Bose C, Hindle A, Lee J, Kopel J, Tonk S, Palade PT, Singhal SS, Awasthi S, Singh SP. Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells. Cancers. 13. PMID 34944997 DOI: 10.3390/cancers13246377 |
0.746 |
|
2021 |
Singh SP, Lee J, Bose C, Li H, Yuan YC, Hindle A, Singhal SS, Kopel J, Palade PT, Jones C, Rahman RL, Awasthi S. Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis. Cancers. 13. PMID 34283045 DOI: 10.3390/cancers13133329 |
0.736 |
|
2021 |
Mirzapoiazova T, Xiao G, Mambetsariev B, Nasser MW, Miaou E, Singhal SS, Srivastava S, Mambetsariev I, Nelson MS, Nam A, Behal A, Atri P, Müschen M, Tissot FLH, Miser J, et al. Protein phosphatase 2A as a therapeutic target in small cell lung cancer. Molecular Cancer Therapeutics. PMID 34253596 DOI: 10.1158/1535-7163.MCT-21-0013 |
0.313 |
|
2021 |
Singhal SS, Srivastava S, Mirzapoiazova T, Horne D, Awasthi S, Salgia R. Targeting the mercapturic acid pathway for the treatment of melanoma. Cancer Letters. PMID 34126193 DOI: 10.1016/j.canlet.2021.06.004 |
0.739 |
|
2021 |
Singhal SS, Mohanty A, Kulkarni P, Horne D, Awasthi S, Salgia R. RLIP Depletion Induces Apoptosis Associated with Inhibition of JAK2/STAT3 Signaling in Melanoma Cells. Carcinogenesis. PMID 33623991 DOI: 10.1093/carcin/bgab016 |
0.781 |
|
2021 |
Singhal J, Kulkarni P, Horne D, Awasthi S, Salgia R, Singhal SS. Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP. Molecular Carcinogenesis. PMID 33544936 DOI: 10.1002/mc.23285 |
0.739 |
|
2021 |
Singhal SS, Horne D, Singhal J, Awasthi S, Salgia R. Activating p53 function by targeting RLIP. Biochimica Et Biophysica Acta. Reviews On Cancer. 188512. PMID 33460725 DOI: 10.1016/j.bbcan.2021.188512 |
0.757 |
|
2020 |
Bose C, Yadav S, Singhal SS, Singhal J, Hindle A, Lee J, Cheedella NKS, Rehman S, Rahman RL, Jones C, Darden M, Palade PT, Berz D, Singh SP, Awasthi S. Rlip Depletion Suppresses Growth of Breast Cancer. Cancers. 12. PMID 32498332 DOI: 10.3390/Cancers12061446 |
0.771 |
|
2020 |
Singhal J, Chikara S, Horne D, Awasthi S, Salgia R, Singhal SS. Targeting RLIP with CRISPR/Cas9 controls tumor growth. Carcinogenesis. PMID 32426802 DOI: 10.1093/Carcin/Bgaa048 |
0.758 |
|
2020 |
Jana S, Krishna M, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS. Therapeutic targeting of miRNA-216b in cancer. Cancer Letters. 484: 16-28. PMID 32387443 DOI: 10.1016/J.Canlet.2020.04.020 |
0.728 |
|
2020 |
Mirzapoiazova T, Pozhitkov A, Nam A, Mambetsariev I, Nelson MS, Tan YC, Zhang K, Raz D, Singhal S, Nasser MW, Kulkarni P, Batra SK, Sattler M, Salgia R. Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines. International Journal of Oncology. PMID 32236606 DOI: 10.3892/Ijo.2020.5034 |
0.398 |
|
2020 |
Krishna BM, Jana S, Panda AK, Horne D, Awasthi S, Salgia R, Singhal SS. Association of Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case-Control Studies †. Cancers. 12. PMID 32085560 DOI: 10.3390/Cancers12020471 |
0.695 |
|
2020 |
Jana S, Krishna BM, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS. SOX9: The Master Regulator of Cell Fate in Breast Cancer. Biochemical Pharmacology. 113789. PMID 31911091 DOI: 10.1016/J.Bcp.2019.113789 |
0.755 |
|
2020 |
Singhal SS, Salgia R, Verma N, Horne D, Awasthi S. RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosis. Biochimica Et Biophysica Acta. Reviews On Cancer. 1873: 188337. PMID 31904398 DOI: 10.1016/J.Bbcan.2020.188337 |
0.748 |
|
2020 |
Awasthi S, Bose C, Jones C, Rahman R, Singhal SS, Singh SP. Abstract P3-11-18: Partial RALBP1 loss depletes DNA repair pathway genes Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-11-18 |
0.418 |
|
2019 |
Bose C, Singh SP, Igid H, Green WC, Singhal SS, Lee J, Palade PT, Rajan A, Ball S, Tonk V, Hindle A, Tarbox M, Awasthi S. Topical 2'-Hydroxyflavanone for Cutaneous Melanoma. Cancers. 11. PMID 31615091 DOI: 10.3390/Cancers11101556 |
0.741 |
|
2019 |
Krishna BM, Jana S, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS. Notch signaling in breast cancer: From pathway analysis to therapy. Cancer Letters. 461: 123-131. PMID 31326555 DOI: 10.1016/J.Canlet.2019.07.012 |
0.759 |
|
2019 |
Singhal SS, Horne D, Singhal J, Vonderfecht S, Salgia R, Awasthi S. Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice. Molecular Carcinogenesis. PMID 31006917 DOI: 10.1002/Mc.23026 |
0.74 |
|
2019 |
Singhal SS, Salgia R, Singhal S, Horne D, Awasthi S. RLIP: An existential requirement for breast carcinogenesis. Biochimica Et Biophysica Acta. Reviews On Cancer. 1871: 281-288. PMID 30771458 DOI: 10.1016/J.Bbcan.2019.02.001 |
0.792 |
|
2019 |
Singhal J, Chikara S, Horne D, Salgia R, Awasthi S, Singhal SS. RLIP inhibition suppresses breast-to-lung metastasis. Cancer Letters. 447: 24-32. PMID 30684594 DOI: 10.1016/J.Canlet.2019.01.023 |
0.745 |
|
2019 |
Singhal SS, Chikara S, Singhal J, Horne D, Salgia R, Awasthi S. Abstract 4801: 2’-Hydroxyflavanone, a diet-derived citrus bioflavonoid, inhibitsin vitroandin vivogrowth of breast cancer cells by targeting RLIP Cancer Research. 79: 4801-4801. DOI: 10.1158/1538-7445.Am2019-4801 |
0.382 |
|
2018 |
Figarola JL, Singhal J, Singhal S, Kusari J, Riggs A. Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas. Oncotarget. 9: 36945-36965. PMID 30651927 DOI: 10.18632/Oncotarget.26421 |
0.359 |
|
2018 |
Awasthi S, Singhal SS, Singhal J, Nagaprashantha L, Li H, Yuan YC, Liu Z, Berz D, Igid H, Green WC, Tijani L, Tonk V, Rajan A, Awasthi Y, Singh SP. Anticancer activity of 2'-hydroxyflavanone towards lung cancer. Oncotarget. 9: 36202-36219. PMID 30546837 DOI: 10.18632/Oncotarget.26329 |
0.779 |
|
2018 |
Nagaprashantha LD, Singhal J, Chikara S, Gugiu G, Horne D, Awasthi S, Salgia R, Singhal SS. 2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells. Journal of Proteomics. PMID 30248461 DOI: 10.1016/J.Jprot.2018.09.005 |
0.755 |
|
2018 |
Singhal J, Singhal P, Horne D, Salgia R, Awasthi S, Singhal SS. Metastasis of Breast Tumor Cells to Brain is suppressed by Targeting RLIP alone and in combination with 2'-Hydroxyflavanone. Cancer Letters. PMID 30223070 DOI: 10.1016/J.Canlet.2018.09.015 |
0.737 |
|
2018 |
Singhal J, Chikara S, Horne D, Salgia R, Awasthi S, Singhal SS. 2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76. Molecular Carcinogenesis. PMID 30136444 DOI: 10.1002/Mc.22894 |
0.768 |
|
2018 |
Nagaprashantha LD, Singhal J, Li H, Warden C, Liu X, Horne D, Awasthi S, Salgia R, Singhal SS. 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer. Oncotarget. 9: 18053-18068. PMID 29719590 DOI: 10.18632/Oncotarget.24720 |
0.768 |
|
2018 |
Awasthi S, Tompkins J, Singhal J, Riggs AD, Yadav S, Wu X, Singh S, Warden C, Liu Z, Wang J, Slavin TP, Weitzel JN, Yuan YC, Awasthi M, Srivastava SK, ... ... Singhal SS, et al. Rlip depletion prevents spontaneous neoplasia in TP53 null mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 29572430 DOI: 10.1073/Pnas.1719586115 |
0.766 |
|
2018 |
Singhal SS, Chikara S, Nagaprashantha L, Singhal J, Horne D, Awasthi S. Abstract 3269A: 2-Hydroxyflavanone: A novel estrogen receptor alpha downregulator with potent antitumor effect in breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-3269A |
0.398 |
|
2017 |
Chikara S, Nagaprashantha LD, Singhal J, Horne D, Awasthi S, Singhal SS. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Cancer Letters. PMID 29113871 DOI: 10.1016/J.Canlet.2017.11.002 |
0.745 |
|
2017 |
Singhal J, Nagaprashantha L, Chikara S, Awasthi S, Horne D, Singhal SS. 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer. Oncotarget. 8: 75025-75037. PMID 29088842 DOI: 10.18632/Oncotarget.20499 |
0.758 |
|
2017 |
Nagaprashantha LD, Adhikari R, Singhal J, Chikara S, Awasthi S, Horne D, Singhal S. Translational Opportunities for Broad-Spectrum Natural Phytochemicals and Targeted Agent Combinations in Breast Cancer. International Journal of Cancer. PMID 28975625 DOI: 10.1002/Ijc.31085 |
0.745 |
|
2017 |
Singhal SS, Nagaprashantha L, Singhal P, Singhal S, Singhal J, Awasthi S, Horne D. RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma. Pharmaceutical Research. PMID 28386633 DOI: 10.1007/S11095-017-2154-Y |
0.767 |
|
2017 |
Singhal SS, Jain D, Singhal P, Awasthi S, Singhal J, Horne D. Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer. Biochimica Et Biophysica Acta. PMID 28359741 DOI: 10.1016/J.Bbcan.2017.03.009 |
0.766 |
|
2017 |
Singhal SS, Singhal S, Singhal P, Singhal J, Horne D, Awasthi S. Didymin: an orally active citrus flavonoid for targeting neuroblastoma. Oncotarget. PMID 28187004 DOI: 10.18632/Oncotarget.15204 |
0.767 |
|
2017 |
Singhal SS, Singhal J, Tompkins J, Horne D, Wu X, Riggs A, Awasthi S. Abstract 5244: Partial knockdown of RLIP76 prevents cancer susceptibility of p53 null mice Cancer Research. 77: 5244-5244. DOI: 10.1158/1538-7445.Am2017-5244 |
0.331 |
|
2016 |
Singhal SS, Figarola J, Singhal J, Tompkins J, Horne D, Awasthi S, Riggs A. Abstract 220: SR4 uncouples mitochondrial oxidative-phosphorylation, modulates AMPK-mTOR signaling, and inhibits proliferation of HepG2 hepatocarcinoma cells Cancer Research. 76: 220-220. DOI: 10.1158/1538-7445.Am2016-220 |
0.34 |
|
2015 |
Figarola JL, Singhal J, Tompkins JD, Rogers GW, Warden C, Horne D, Riggs AD, Awasthi S, Singhal SS. SR4 Uncouples Mitochondrial Oxidative Phosphorylation, Modulates AMPK-mTOR Signaling, and Inhibits Proliferation of HepG2 Hepatocarcinoma Cells. The Journal of Biological Chemistry. PMID 26534958 DOI: 10.1074/Jbc.M115.686352 |
0.728 |
|
2015 |
Wurtzel JG, Lee S, Singhal SS, Awasthi S, Ginsberg MH, Goldfinger LE. RLIP76 regulates Arf6-dependent cell spreading and migration by linking ARNO with activated R-Ras at recycling endosomes. Biochemical and Biophysical Research Communications. 467: 785-91. PMID 26498519 DOI: 10.1016/J.Bbrc.2015.10.064 |
0.703 |
|
2015 |
Singhal SS, Singh SP, Singhal P, Horne D, Singhal J, Awasthi S. Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling. Toxicology and Applied Pharmacology. PMID 26476300 DOI: 10.1016/J.Taap.2015.10.006 |
0.751 |
|
2015 |
Singhal SS, Singhal J, Figarola J, Horne D, Awasthi S. RLIP76 Targeted Therapy for Kidney Cancer. Pharmaceutical Research. 32: 3123-36. PMID 26021465 DOI: 10.1007/S11095-015-1723-1 |
0.79 |
|
2015 |
Singhal SS, Singhal J, Figarola JL, Riggs A, Horne D, Awasthi S. 2'-Hydroxyflavanone: A promising molecule for kidney cancer prevention. Biochemical Pharmacology. 96: 151-8. PMID 25957660 DOI: 10.1016/J.Bcp.2015.04.022 |
0.756 |
|
2014 |
Figarola JL, Singhal J, Rahbar S, Awasthi S, Singhal SS. LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells. Apoptosis : An International Journal On Programmed Cell Death. 19: 776-88. PMID 24615331 DOI: 10.1007/S10495-014-0974-3 |
0.74 |
|
2014 |
Singhal SS, Figarola J, Singhal J, Nagaprashantha L, Berz D, Rahbar S, Awasthi S. Abstract 2149: Novel compound 1, 3-bis (3, 5-dichlorophenyl) urea inhibits lung cancer progression Cancer Research. 74: 2149-2149. DOI: 10.1158/1538-7445.Am2014-2149 |
0.434 |
|
2013 |
Figarola JL, Singhal P, Rahbar S, Gugiu BG, Awasthi S, Singhal SS. COH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese mice. Plos One. 8: e83801. PMID 24376752 DOI: 10.1371/Journal.Pone.0083801 |
0.721 |
|
2013 |
Singhal SS, Figarola J, Singhal J, Nagaprashantha L, Berz D, Rahbar S, Awasthi S. Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression. Biochemical Pharmacology. 86: 1664-72. PMID 24099794 DOI: 10.1016/J.Bcp.2013.09.022 |
0.779 |
|
2013 |
Nagaprashantha LD, Talamantes T, Singhal J, Guo J, Vatsyayan R, Rauniyar N, Awasthi S, Singhal SS, Prokai L. Proteomic analysis of signaling network regulation in renal cell carcinomas with differential hypoxia-inducible factor-2α expression. Plos One. 8: e71654. PMID 23940778 DOI: 10.1371/Journal.Pone.0071654 |
0.789 |
|
2013 |
Singhal SS, Figarola J, Singhal J, Reddy MA, Liu X, Berz D, Natarajan R, Awasthi S. RLIP76 protein knockdown attenuates obesity due to a high-fat diet. The Journal of Biological Chemistry. 288: 23394-406. PMID 23821548 DOI: 10.1074/Jbc.M113.480194 |
0.715 |
|
2013 |
Yadav A, Janaratne T, Krishnan A, Singhal SS, Yadav S, Dayoub AS, Hawkins DL, Awasthi S, MacDonnell FM. Regression of lung cancer by hypoxia-sensitizing ruthenium polypyridyl complexes. Molecular Cancer Therapeutics. 12: 643-53. PMID 23443803 DOI: 10.1158/1535-7163.Mct-12-1130 |
0.739 |
|
2013 |
Vatsyayan R, Singhal J, Nagaprashantha LD, Awasthi S, Singhal SS. Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma. Molecular Carcinogenesis. 52: 39-48. PMID 22006587 DOI: 10.1002/Mc.20875 |
0.745 |
|
2013 |
Nagaprashantha LPGD, Figarola J, Singhal J, Horne D, Jove R, Rahbar S, Awasthi S, Singhal SS. Abstract 5518: A novel 1,3-bis(3,5-dichlorophenyl) urea compound ‘COH-SR4’ for targeting melanoma. Cancer Research. 73: 5518-5518. DOI: 10.1158/1538-7445.Am2013-5518 |
0.388 |
|
2012 |
Singhal SS, Figarola J, Singhal J, Leake K, Nagaprashantha L, Lincoln C, Gabriel Gugiu B, Horne D, Jove R, Awasthi S, Rahbar S. 1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma. Biochemical Pharmacology. 84: 1419-27. PMID 22959823 DOI: 10.1016/J.Bcp.2012.08.020 |
0.753 |
|
2012 |
Lee S, Wurtzel JG, Singhal SS, Awasthi S, Goldfinger LE. RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization. Cancer Research. 72: 5165-73. PMID 22902412 DOI: 10.1158/0008-5472.Can-12-0468 |
0.724 |
|
2012 |
Leake K, Singhal J, Nagaprashantha LD, Awasthi S, Singhal SS. RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer. Plos One. 7: e34582. PMID 22509328 DOI: 10.1371/Journal.Pone.0034582 |
0.765 |
|
2012 |
Nagaprashantha L, Vartak N, Awasthi S, Awasthi S, Singhal SS. Novel anti-cancer compounds for developing combinatorial therapies to target anoikis-resistant tumors. Pharmaceutical Research. 29: 621-36. PMID 22203324 DOI: 10.1007/S11095-011-0645-9 |
0.763 |
|
2012 |
Singhal J, Nagaprashantha LD, Vatsyayan R, Ashutosh, Awasthi S, Singhal SS. Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma. Cancer Prevention Research (Philadelphia, Pa.). 5: 473-83. PMID 22174364 DOI: 10.1158/1940-6207.Capr-11-0318 |
0.747 |
|
2012 |
Dalasanur Nagaprashantha LPG, Talamantes T, Singhal J, Awasthi S, Singhal SS, Prokai L. The impact of novel compound 2'-hydroxyflavanone on proteomic networks of VHL-mutant renal cell carcinoma. Journal of Clinical Oncology. 30: e13557-e13557. DOI: 10.1200/Jco.2012.30.15_Suppl.E13557 |
0.779 |
|
2012 |
Singhal S. Novel flavonoid didymin inhibits neuroblastomas - Response Cancer Prevention Research. 5: 884-885. DOI: 10.1158/1940-6207.Capr-12-0153 |
0.314 |
|
2012 |
Leake K, Singhal SS, Awasthi S. Abstract PR8: Targeted therapy for pancreatic cancer. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-Pr8 |
0.45 |
|
2012 |
Nagaprashantha L, Singhal J, Awasthi S, Singhal SS. Abstract 3700: Anticancer effects and mechanisms of action of novel flavonoid didymin in neuroblastomas Cancer Research. 72: 3700-3700. DOI: 10.1158/1538-7445.Am2012-3700 |
0.767 |
|
2012 |
Singhal SS, Nagaprashantha L, Singhal J, Awasthi S. Abstract 2697: Role of a novel flavonoid enriched in ocimum sanctum linn for prostate cancer chemoprevention and therapy Cancer Research. 72: 2697-2697. DOI: 10.1158/1538-7445.Am2012-2697 |
0.764 |
|
2011 |
Dalasanur Nagaprashantha LP, Singhal J, Vatsyayan R, Awasthi S, Singhal SS. The impact of a novel vicenin-2 and oral docetaxel combinatorial regimen in androgen-independent prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e13534. PMID 28022720 DOI: 10.1200/jco.2011.29.15_suppl.e13534 |
0.719 |
|
2011 |
Singhal J, Nagaprashantha L, Vatsyayan R, Awasthi S, Singhal SS. RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome. Plos One. 6: e24688. PMID 21931813 DOI: 10.1371/Journal.Pone.0024688 |
0.72 |
|
2011 |
Nagaprashantha LD, Vatsyayan R, Singhal J, Fast S, Roby R, Awasthi S, Singhal SS. Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. Biochemical Pharmacology. 82: 1100-9. PMID 21803027 DOI: 10.1016/J.Bcp.2011.07.078 |
0.76 |
|
2011 |
Singhal J, Yadav S, Nagaprashantha LD, Vatsyayan R, Singhal SS, Awasthi S. Targeting p53-null neuroblastomas through RLIP76. Cancer Prevention Research (Philadelphia, Pa.). 4: 879-89. PMID 21411502 DOI: 10.1158/1940-6207.Capr-11-0025 |
0.751 |
|
2011 |
Nagaprashantha LD, Vatsyayan R, Singhal J, Lelsani P, Prokai L, Awasthi S, Singhal SS. 2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma. Carcinogenesis. 32: 568-75. PMID 21304051 DOI: 10.1093/Carcin/Bgr021 |
0.785 |
|
2011 |
Singhal SS, Wickramarachchi D, Yadav S, Singhal J, Leake K, Vatsyayan R, Chaudhary P, Lelsani P, Suzuki S, Yang S, Awasthi YC, Awasthi S. Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis. Molecular Cancer Therapeutics. 10: 16-28. PMID 21220488 DOI: 10.1158/1535-7163.Mct-10-0699 |
0.818 |
|
2011 |
Nagaprashantha LD, Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS. The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors. International Journal of Cancer. 128: 743-52. PMID 20949625 DOI: 10.1002/Ijc.25725 |
0.741 |
|
2011 |
Singhal SS, Yadav S, Wickramachchi D, Singhal J, Leake K, Vatsyayan R, Chaudhary P, Awasthi Y, Awasthi S. Abstract 5547: Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis Cancer Research. 71: 5547-5547. DOI: 10.1158/1538-7445.Am2011-5547 |
0.419 |
|
2011 |
Vatsyayan R, Singhal J, Yadav S, Nagaprashantha LD, Singhal SS, Awasthi S. Abstract 4334: Targeting p53 null neuroblastomas through RLIP76 Cancer Research. 71: 4334-4334. DOI: 10.1158/1538-7445.Am2011-4334 |
0.402 |
|
2011 |
Nagaprashantha LD, Vatsyayan R, Singhal J, Lelsani P, Awasthi Y, Awasthi S, Singhal SS. Abstract 3702: 2-Hydroxyflavanone inhibits renal cancer growth by inhibiting tumor cell proliferation and angiogenesis Cancer Research. 71: 3702-3702. DOI: 10.1158/1538-7445.Am2011-3702 |
0.391 |
|
2010 |
Chaudhary P, Sharma R, Sharma A, Vatsyayan R, Yadav S, Singhal SS, Rauniyar N, Prokai L, Awasthi S, Awasthi YC. Mechanisms of 4-hydroxy-2-nonenal induced pro- and anti-apoptotic signaling. Biochemistry. 49: 6263-75. PMID 20565132 DOI: 10.1021/Bi100517X |
0.793 |
|
2010 |
Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS. RLIP76: a versatile transporter and an emerging target for cancer therapy. Biochemical Pharmacology. 79: 1699-705. PMID 20097178 DOI: 10.1016/J.Bcp.2010.01.016 |
0.797 |
|
2010 |
Awasthi S, Singhal SS, Yadav S, Singhal J, Vatsyayan R, Zajac E, Luchowski R, Borvak J, Gryczynski K, Awasthi YC. A central role of RLIP76 in regulation of glycemic control. Diabetes. 59: 714-25. PMID 20007934 DOI: 10.2337/Db09-0911 |
0.783 |
|
2010 |
Singhal SS, Sehrawat A, Sahu M, Singhal P, Vatsyayan R, Rao Lelsani PC, Yadav S, Awasthi S. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. International Journal of Cancer. 126: 1327-38. PMID 19626587 DOI: 10.1002/Ijc.24767 |
0.784 |
|
2010 |
Dalasanur Nagaprashantha L, Singhal J, Vatsyayan R, Lelsani P, Singhal SS, Prokai L, Awasthi S. Proteomic analysis of drug metabolizing networks in renal cell carcinomas with differential drug sensitivity and VHL expression. Journal of Clinical Oncology. 28: e13137-e13137. DOI: 10.1200/Jco.2010.28.15_Suppl.E13137 |
0.772 |
|
2010 |
Ramana KV, Tammali R, Singhal SS, Awasthi S, Srivastava SK. Abstract 3233: Inhibition of aldose reductase prevents lung cancer cell growthin vitroandin vivo Cancer Research. 70: 3233-3233. DOI: 10.1158/1538-7445.Am10-3233 |
0.415 |
|
2010 |
Singhal SS, Sehrawat A, Sahu M, Singhal P, Vatsyayan R, Lelsani PCR, Yadav S, Awasthi S. Abstract 1525: RLIP76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer Cancer Research. 70: 1525-1525. DOI: 10.1158/1538-7445.Am10-1525 |
0.468 |
|
2009 |
Yadav S, Singhal J, Singhal SS, Awasthi S. hSET1: a novel approach for colon cancer therapy. Biochemical Pharmacology. 77: 1635-41. PMID 19426701 DOI: 10.1016/J.Bcp.2009.02.019 |
0.756 |
|
2009 |
Vatsyayan R, Chaudhary P, Lelsani PC, Singhal P, Awasthi YC, Awasthi S, Singhal SS. Role of RLIP76 in doxorubicin resistance in lung cancer. International Journal of Oncology. 34: 1505-11. PMID 19424567 DOI: 10.3892/Ijo_00000279 |
0.747 |
|
2009 |
Singhal SS, Singhal J, Yadav S, Sahu M, Awasthi YC, Awasthi S. RLIP76: a target for kidney cancer therapy. Cancer Research. 69: 4244-51. PMID 19417134 DOI: 10.1158/0008-5472.Can-08-3521 |
0.781 |
|
2009 |
Singhal SS, Yadav S, Vatsyayan R, Chaudhary P, Borvak J, Singhal J, Awasthi S. Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis. Cancer Letters. 283: 152-8. PMID 19375851 DOI: 10.1016/J.Canlet.2009.03.033 |
0.781 |
|
2009 |
Singhal SS, Sehrawat A, Mehta A, Sahu M, Awasthi S. Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates. International Journal of Oncology. 34: 191-9. PMID 19082490 DOI: 10.3892/Ijo_00000141 |
0.767 |
|
2009 |
Singhal SS, Roth C, Leake K, Singhal J, Yadav S, Awasthi S. Regression of prostate cancer xenografts by RLIP76 depletion. Biochemical Pharmacology. 77: 1074-83. PMID 19073149 DOI: 10.1016/J.Bcp.2008.11.013 |
0.793 |
|
2009 |
Singhal SS, Yadav S, Roth C, Singhal J. RLIP76: A novel glutathione-conjugate and multi-drug transporter. Biochemical Pharmacology. 77: 761-9. PMID 18983828 DOI: 10.1016/J.Bcp.2008.10.006 |
0.44 |
|
2009 |
Borvak J, Singhal J, Singhal S, Yadav S, Sahu M, Awasthi Y, Awasthi S. The Role of RLIP76 in Dendritic Cell-Based Immunotherapies. Blood. 114: 3689-3689. DOI: 10.1182/Blood.V114.22.3689.3689 |
0.327 |
|
2008 |
Warnke MM, Wanigasekara E, Singhal SS, Singhal J, Awasthi S, Armstrong DW. The determination of glutathione-4-hydroxynonenal (GSHNE), E-4-hydroxynonenal (HNE), and E-1-hydroxynon-2-en-4-one (HNO) in mouse liver tissue by LC-ESI-MS. Analytical and Bioanalytical Chemistry. 392: 1325-33. PMID 18815773 DOI: 10.1007/S00216-008-2383-3 |
0.715 |
|
2008 |
Singhal J, Singhal SS, Yadav S, Suzuki S, Warnke MM, Yacoub A, Dent P, Bae S, Sharma R, Awasthi YC, Armstrong DW, Awasthi S. RLIP76 in defense of radiation poisoning. International Journal of Radiation Oncology, Biology, Physics. 72: 553-61. PMID 18793957 DOI: 10.1016/J.Ijrobp.2008.06.1497 |
0.739 |
|
2008 |
Singhal SS, Yadav S, Singhal J, Sahu M, Sehrawat A, Awasthi S. Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76. Febs Letters. 582: 3408-14. PMID 18789326 DOI: 10.1016/J.Febslet.2008.09.001 |
0.748 |
|
2008 |
Awasthi S, Singhal SS, Awasthi YC, Martin B, Woo JH, Cunningham CC, Frankel AE. RLIP76 and Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4372-7. PMID 18628450 DOI: 10.1158/1078-0432.Ccr-08-0145 |
0.743 |
|
2008 |
Singhal SS, Yadav S, Drake K, Singhal J, Awasthi S. Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1. The Journal of Biological Chemistry. 283: 19714-29. PMID 18474607 DOI: 10.1074/Jbc.M708703200 |
0.814 |
|
2008 |
Awasthi YC, Sharma R, Sharma A, Yadav S, Singhal SS, Chaudhary P, Awasthi S. Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. Free Radical Biology & Medicine. 45: 111-8. PMID 18456001 DOI: 10.1016/J.Freeradbiomed.2008.04.007 |
0.738 |
|
2007 |
Janigro D, Awasthi S, Awasthi YC, Sharma R, Yadav S, Singhal SS, Hallene K. RLIP76 in AED drug resistance. Epilepsia. 48: 1218-9; author reply. PMID 17553125 DOI: 10.1111/J.1528-1167.2007.01155_4.X |
0.706 |
|
2007 |
Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, Awasthi S. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Research. 67: 4382-9. PMID 17483352 DOI: 10.1158/0008-5472.Can-06-4124 |
0.778 |
|
2007 |
Singhal SS, Singhal J, Nair MP, Lacko AG, Awasthi YC, Awasthi S. Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. International Journal of Oncology. 30: 717-25. PMID 17273774 DOI: 10.3892/Ijo.30.3.717 |
0.752 |
|
2007 |
Yadav S, Zajac E, Singhal SS, Awasthi S. Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters. Cancer Metastasis Reviews. 26: 59-69. PMID 17260165 DOI: 10.1007/S10555-007-9043-5 |
0.817 |
|
2007 |
Drake KJ, Singhal J, Yadav S, Nadkar A, Pungaliya C, Singhal SS, Awasthi S. RALBP1/RLIP76 mediates multidrug resistance. International Journal of Oncology. 30: 139-44. PMID 17143522 DOI: 10.3892/Ijo.30.1.139 |
0.804 |
|
2006 |
Tammali R, Ramana KV, Singhal SS, Awasthi S, Srivastava SK. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Research. 66: 9705-13. PMID 17018629 DOI: 10.1158/0008-5472.Can-06-2105 |
0.75 |
|
2006 |
Nadkar A, Pungaliya C, Drake K, Zajac E, Singhal SS, Awasthi S. Therapeutic resistance in lung cancer. Expert Opinion On Drug Metabolism & Toxicology. 2: 753-77. PMID 17014393 DOI: 10.1517/17425255.2.5.753 |
0.801 |
|
2006 |
Singhal SS, Yadav S, Singhal J, Awasthi YC, Awasthi S. Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76. Biochemical and Biophysical Research Communications. 348: 722-7. PMID 16890208 DOI: 10.1016/J.Bbrc.2006.07.118 |
0.733 |
|
2006 |
Singhal SS, Wickramarachchi D, Singhal J, Yadav S, Awasthi YC, Awasthi S. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC. Febs Letters. 580: 2258-64. PMID 16579994 DOI: 10.1016/J.Febslet.2006.03.038 |
0.812 |
|
2006 |
Singhal SS, Awasthi YC, Awasthi S. Regression of melanoma in a murine model by RLIP76 depletion. Cancer Research. 66: 2354-60. PMID 16489041 DOI: 10.1158/0008-5472.Can-05-3534 |
0.764 |
|
2005 |
Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D. RLIP76, a non-ABC transporter, and drug resistance in epilepsy. Bmc Neuroscience. 6: 61. PMID 16188027 DOI: 10.1186/1471-2202-6-61 |
0.725 |
|
2005 |
Singhal SS, Yadav S, Singhal J, Drake K, Awasthi YC, Awasthi S. The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer. Febs Letters. 579: 4635-41. PMID 16087181 DOI: 10.1016/J.Febslet.2005.07.032 |
0.794 |
|
2005 |
Awasthi S, Singhal SS, Yadav S, Singhal J, Drake K, Nadkar A, Zajac E, Wickramarachchi D, Rowe N, Yacoub A, Boor P, Dwivedi S, Dent P, Jarman WE, John B, et al. RLIP76 is a major determinant of radiation sensitivity. Cancer Research. 65: 6022-8. PMID 16024601 DOI: 10.1158/0008-5472.Can-05-0968 |
0.783 |
|
2005 |
Singhal SS, Yadav S, Singhal J, Zajac E, Awasthi YC, Awasthi S. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin. Biochemical Pharmacology. 70: 481-8. PMID 15950949 DOI: 10.1016/J.Bcp.2005.05.005 |
0.826 |
|
2005 |
Yadav S, Zajac E, Singhal SS, Singhal J, Drake K, Awasthi YC, Awasthi S. POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis. Biochemical and Biophysical Research Communications. 328: 1003-9. PMID 15707977 DOI: 10.1016/J.Bbrc.2005.01.055 |
0.825 |
|
2005 |
Stuckler D, Singhal J, Singhal SS, Yadav S, Awasthi YC, Awasthi S. RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. Cancer Research. 65: 991-8. PMID 15705900 |
0.763 |
|
2004 |
Yadav S, Singhal SS, Singhal J, Wickramarachchi D, Knutson E, Albrecht TB, Awasthi YC, Awasthi S. Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses. Biochemistry. 43: 16243-53. PMID 15610018 DOI: 10.1021/Bi0482811 |
0.786 |
|
2004 |
Sharma R, Singhal SS, Wickramarachchi D, Awasthi YC, Awasthi S. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance. International Journal of Cancer. Journal International Du Cancer. 112: 934-42. PMID 15386349 DOI: 10.1002/Ijc.20516 |
0.814 |
|
2003 |
Awasthi YC, Sharma R, Cheng JZ, Yang Y, Sharma A, Singhal SS, Awasthi S. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Molecular Aspects of Medicine. 24: 219-30. PMID 12893000 DOI: 10.1016/S0098-2997(03)00017-7 |
0.737 |
|
2003 |
Yang Y, Sharma A, Sharma R, Patrick B, Singhal SS, Zimniak P, Awasthi S, Awasthi YC. Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. The Journal of Biological Chemistry. 278: 41380-8. PMID 12888579 DOI: 10.1074/Jbc.M305766200 |
0.748 |
|
2003 |
Sharma R, Yang Y, Sharma A, Dwivedi S, Popov VL, Boor PJ, Singhal SS, Awasthi S, Awasthi YC. Mechanisms and physiological significance of the transport of the glutathione conjugate of 4-hydroxynonenal in human lens epithelial cells. Investigative Ophthalmology & Visual Science. 44: 3438-49. PMID 12882793 DOI: 10.1167/Iovs.03-0051 |
0.745 |
|
2003 |
Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. International Journal of Cancer. Journal International Du Cancer. 106: 635-46. PMID 12866021 DOI: 10.1002/Ijc.11260 |
0.743 |
|
2003 |
Sharma R, Awasthi YC, Yang Y, Sharma A, Singhal SS, Awasthi S. Energy dependent transport of xenobiotics and its relevance to multidrug resistance. Current Cancer Drug Targets. 3: 89-107. PMID 12678713 DOI: 10.2174/1568009033482047 |
0.772 |
|
2003 |
Awasthi S, Singhal SS, Singhal J, Yang Y, Zimniak P, Awasthi YC. Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity. International Journal of Oncology. 22: 721-32. PMID 12632061 DOI: 10.3892/Ijo.22.4.721 |
0.754 |
|
2003 |
Awasthi S, Singhal SS, Singhal J, Cheng J, Zimniak P, Awasthi YC. Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76. International Journal of Oncology. 22: 713-20. PMID 12632060 DOI: 10.3892/Ijo.22.4.713 |
0.76 |
|
2003 |
Singhal SS, Singhal J, Sharma R, Singh SV, Zimniak P, Awasthi YC, Awasthi S. Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells. International Journal of Oncology. 22: 365-75. PMID 12527936 DOI: 10.3892/Ijo.22.2.365 |
0.76 |
|
2002 |
Awasthi S, Sharma R, Yang Y, Singhal SS, Pikula S, Bandorowicz-Pikula J, Singh SV, Zimniak P, Awasthi YC. Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76). Acta Biochimica Polonica. 49: 855-67. PMID 12545192 DOI: 10.18388/Abp.2002_3745 |
0.751 |
|
2002 |
Awasthi S, Sharma R, Singhal SS, Zimniak P, Awasthi YC. RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 1300-10. PMID 12433796 DOI: 10.1124/Dmd.30.12.1300 |
0.775 |
|
2002 |
Sharma R, Sharma A, Yang Y, Awasthi S, Singhal SS, Zimniak P, Awasthi YC. Functional reconstitution of Ral-binding GTPase activating protein, RLIP76, in proteoliposomes catalyzing ATP-dependent transport of glutathione conjugate of 4-hydroxynonenal. Acta Biochimica Polonica. 49: 693-701. PMID 12422239 DOI: 10.18388/Abp.2002_3778 |
0.727 |
|
2001 |
Cheng JZ, Sharma R, Yang Y, Singhal SS, Sharma A, Saini MK, Singh SV, Zimniak P, Awasthi S, Awasthi YC. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. The Journal of Biological Chemistry. 276: 41213-23. PMID 11522795 DOI: 10.1074/Jbc.M106838200 |
0.737 |
|
2001 |
Cheng JZ, Singhal SS, Sharma A, Saini M, Yang Y, Awasthi S, Zimniak P, Awasthi YC. Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling. Archives of Biochemistry and Biophysics. 392: 197-207. PMID 11488593 DOI: 10.1006/Abbi.2001.2452 |
0.731 |
|
2001 |
Sharma R, Singhal SS, Cheng J, Yang Y, Sharma A, Zimniak P, Awasthi S, Awasthi YC. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes. Archives of Biochemistry and Biophysics. 391: 171-9. PMID 11437348 DOI: 10.1006/Abbi.2001.2395 |
0.735 |
|
2001 |
Cheng JZ, Yang Y, Singh SP, Singhal SS, Awasthi S, Pan SS, Singh SV, Zimniak P, Awasthi YC. Two distinct 4-hydroxynonenal metabolizing glutathione S-transferase isozymes are differentially expressed in human tissues. Biochemical and Biophysical Research Communications. 282: 1268-74. PMID 11302754 DOI: 10.1006/Bbrc.2001.4707 |
0.699 |
|
2001 |
Awasthi S, Cheng JZ, Singhal SS, Pandya U, Sharma R, Singh SV, Zimniak P, Awasthi YC. Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences. Biochemistry. 40: 4159-68. PMID 11300797 DOI: 10.1021/Bi002182F |
0.729 |
|
2001 |
Yang Y, Cheng JZ, Singhal SS, Saini M, Pandya U, Awasthi S, Awasthi YC. Role of glutathione S-transferases in protection against lipid peroxidation. Overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation. The Journal of Biological Chemistry. 276: 19220-30. PMID 11279091 DOI: 10.1074/Jbc.M100551200 |
0.728 |
|
2001 |
Pandya U, Srivastava SK, Singhal SS, Pal A, Awasthi S, Zimniak P, Awasthi YC, Singh SV. Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. Biochemical and Biophysical Research Communications. 278: 258-62. PMID 11071881 DOI: 10.1006/Bbrc.2000.3787 |
0.731 |
|
2001 |
Singhal SS, Singhal J, Cheng J, Pikuła S, Sharma R, Zimniak P, Awasthi YC, Awasthi S. Purification and functional reconstitution of intact ral-binding Gtpase activating protein, RLIP76, in artificial liposomes. Acta Biochimica Polonica. 48: 551-562. DOI: 10.18388/Abp.2001_3938 |
0.735 |
|
2000 |
Awasthi S, Pandya U, Singhal SS, Lin JT, Thiviyanathan V, Seifert WE, Awasthi YC, Ansari GA. Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1. Chemico-Biological Interactions. 128: 19-38. PMID 10996298 DOI: 10.1016/S0009-2797(00)00185-X |
0.71 |
|
2000 |
Awasthi S, Cheng J, Singhal SS, Saini MK, Pandya U, Pikula S, Bandorowicz-Pikula J, Singh SV, Zimniak P, Awasthi YC. Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry. 39: 9327-34. PMID 10924126 DOI: 10.1021/Bi992964C |
0.765 |
|
1999 |
Cheng JZ, Singhal SS, Saini M, Singhal J, Piper JT, Van Kuijk FJ, Zimniak P, Awasthi YC, Awasthi S. Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells. Archives of Biochemistry and Biophysics. 372: 29-36. PMID 10562413 DOI: 10.1006/Abbi.1999.1479 |
0.715 |
|
1999 |
Singhal SS, Awasthi S, Pandya U, Piper JT, Saini MK, Cheng JZ, Awasthi YC. The effect of curcumin on glutathione-linked enzymes in K562 human leukemia cells. Toxicology Letters. 109: 87-95. PMID 10514034 DOI: 10.1016/S0378-4274(99)00124-1 |
0.735 |
|
1999 |
He N, Singhal SS, Awasthi S, Zhao T, Boor PJ. Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro. Toxicology and Applied Pharmacology. 158: 177-85. PMID 10406932 DOI: 10.1006/Taap.1999.8700 |
0.715 |
|
1999 |
Zhao T, Singhal SS, Piper JT, Cheng J, Pandya U, Clark-Wronski J, Awasthi S, Awasthi YC. The role of human glutathione S-transferases hGSTA1-1 and hGSTA2-2 in protection against oxidative stress. Archives of Biochemistry and Biophysics. 367: 216-24. PMID 10395737 DOI: 10.1006/Abbi.1999.1277 |
0.711 |
|
1999 |
Awasthi S, Singhal SS, Pandya U, Gopal S, Zimniak P, Singh SV, Awasthi YC. ATP-dependent colchicine transport by human erythrocyte glutathione conjugate transporter Toxicology and Applied Pharmacology. 155: 215-226. PMID 10079207 DOI: 10.1006/Taap.1998.8617 |
0.73 |
|
1998 |
He NG, Awasthi S, Singhal SS, Trent MB, Boor PJ. The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall. Toxicology and Applied Pharmacology. 152: 83-9. PMID 9772203 DOI: 10.1006/Taap.1998.8511 |
0.717 |
|
1998 |
Piper JT, Singhal SS, Salameh MS, Torman RT, Awasthi YC, Awasthi S. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. The International Journal of Biochemistry & Cell Biology. 30: 445-56. PMID 9675878 DOI: 10.1016/S1357-2725(98)00015-6 |
0.718 |
|
1998 |
Awasthi S, Singhal SS, Pikula S, Piper JT, Srivastava SK, Torman RT, Bandorowicz-Pikula J, Lin JT, Singh SV, Zimniak P, Awasthi YC. ATP-Dependent human erythrocyte glutathione-conjugate transporter. II. Functional reconstitution of transport activity. Biochemistry. 37: 5239-48. PMID 9548755 DOI: 10.1021/Bi972131R |
0.742 |
|
1998 |
Awasthi S, Singhal SS, Srivastava SK, Torman RT, Zimniak P, Bandorowicz-Pikula J, Singh SV, Piper JT, Awasthi YC, Pikula S. ATP-Dependent human erythrocyte glutathione-conjugate transporter. I. Purification, photoaffinity labeling, and kinetic characteristics of ATPase activity. Biochemistry. 37: 5231-8. PMID 9548754 DOI: 10.1021/Bi972130Z |
0.721 |
|
1998 |
Morrison RJ, Singhal SS, Bidani A, Heming TA, Awasthi S. Glutathione S-transferases of rabbit lung macrophages. Toxicology and Applied Pharmacology. 148: 229-36. PMID 9473530 DOI: 10.1006/Taap.1997.8339 |
0.71 |
|
1997 |
Awasthi S, Singhal SS, Srivastava SK, Chaubey M, Piper JT, Zimniak P, Yallampalli C, Rajaraman S, Awasthi YC. Rat GST 8-8 is expressed predominantly in myeloid origin cells infiltrating the gravid uterus. The International Journal of Biochemistry & Cell Biology. 29: 807-13. PMID 9251248 DOI: 10.1016/S1357-2725(96)00173-2 |
0.715 |
|
1997 |
He NG, Singhal SS, Chaubey M, Awasthi S, Zimniak P, Partridge CA, Awasthi YC. Purification and characterization of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme from bovine pulmonary microvessel endothelial cells. Biochimica Et Biophysica Acta. 1291: 182-8. PMID 8980630 DOI: 10.1016/S0304-4165(96)00064-5 |
0.724 |
|
1997 |
Singhal SS, Piper JT, Srivastava SK, Chaubey M, Bandorowicz-Pikula J, Awasthi S, Awasthi YC. Rabbit aorta glutathione S-transferases and their role in bioactivation of trinitroglycerin. Toxicology and Applied Pharmacology. 140: 378-86. PMID 8887455 DOI: 10.1006/Taap.1996.0234 |
0.711 |
|
1996 |
Singhal SS, Yallampalli C, Singhal J, Piper JT, Awasthi S. Purification and characterization of glutathione S-transferases of rat uterus International Journal of Biochemistry and Cell Biology. 28: 1271-1283. PMID 9022286 DOI: 10.1016/S1357-2725(96)00060-X |
0.698 |
|
1996 |
Srivastava SK, Singhal SS, Awasthi S, Pikula S, Ansari NH, Awasthi YC. A glutathione S-transferases isozyme (bGST 5.8) involved in the metabolism of 4-hydroxy-2-trans-nonenal is localized in bovine lens epithelium Experimental Eye Research. 63: 329-337. PMID 8943706 DOI: 10.1006/Exer.1996.0122 |
0.701 |
|
1996 |
Awasthi S, Singhal SS, He N, Chaubey M, Zimniak P, Srivastava SK, Singh SV, Awasthi YC. Modulation of doxorubicin cytotoxicity by ethacrynic acid. International Journal of Cancer. 68: 333-9. PMID 8903475 DOI: 10.1002/(Sici)1097-0215(19961104)68:3<333::Aid-Ijc11>3.0.Co;2-9 |
0.757 |
|
1996 |
Awasthi S, Srivatava SK, Piper JT, Singhal SS, Chaubey M, Awasthi YC. Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses American Journal of Clinical Nutrition. 64: 761-766. PMID 8901798 DOI: 10.1093/Ajcn/64.5.761 |
0.706 |
|
1996 |
He NG, Singhal SS, Srivastava SK, Zimniak P, Awasthi YC, Awasthi S. Transfection of a 4-hydroxynonenal metabolizing glutathione S- transferase isozyme, mouse GSTA4-4, confers doxorubicin resistance to Chinese hamster ovary cells Archives of Biochemistry and Biophysics. 333: 214-220. PMID 8806773 DOI: 10.1006/Abbi.1996.0383 |
0.722 |
|
1995 |
Khan MF, Srivastava SK, Singhal SS, Chaubey M, Awasthi S, Petersen DR, Ansari GA, Awasthi YC. Iron-induced lipid peroxidation in rat liver is accompanied by preferential induction of glutathione S-transferase 8-8 isozyme. Toxicology and Applied Pharmacology. 131: 63-72. PMID 7878679 DOI: 10.1006/taap.1995.1047 |
0.692 |
|
1995 |
Misra P, Srivastava SK, Singhal SS, Awasthi S, Awasthi YC, Boor PJ. Glutathione S-Transferase 8-8 Is Localized in Smooth Muscle Cells of Rat Aorta and Is Induced in an Experimental Model of Atherosclerosis Toxicology and Applied Pharmacology. 133: 27-33. PMID 7597707 DOI: 10.1006/Taap.1995.1123 |
0.706 |
|
1994 |
Sharma R, Singhal SS, Srivastava SK, Bajpai KK, Frenkel EP, Awasthi S. Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines. Cancer Letters. 75: 111-9. PMID 8293421 DOI: 10.1016/0304-3835(93)90195-F |
0.747 |
|
1994 |
Singhal SS, Zimniak P, Awasthi S, Piper JT, He NG, Teng JI, Petersen DR, Awasthi YC. Several closely related glutathione S-transferase isozymes catalyzing conjugation of 4-hydroxynonenal are differentially expressed in human tissues. Archives of Biochemistry and Biophysics. 311: 242-50. PMID 8203886 DOI: 10.1006/Abbi.1994.1233 |
0.707 |
|
1994 |
Singhal SS, Zimniak P, Sharma R, Srivastava SK, Awasthi S, Awasthi YC. A novel glutathione S-transferase isozyme similar to GST 8-8 of rat and mGSTA4-4 (GST 5.7) of mouse is selectively expressed in human tissues Biochimica Et Biophysica Acta (Bba)/Protein Structure and Molecular. 1204: 279-286. PMID 8142470 DOI: 10.1016/0167-4838(94)90019-1 |
0.709 |
|
1994 |
Zimniak P, Nanduri B, Pikuła S, Bandorowicz-Pikuła J, Singhal SS, Srivastava SK, Awasthi S, Awasthi YC. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. European Journal of Biochemistry. 224: 893-9. PMID 7925413 DOI: 10.1111/J.1432-1033.1994.00893.X |
0.706 |
|
1994 |
Awasthi S, Sharma R, Singhal SS, Herzog NK, Chaubey M, Awasthi YC. Modulation of cisplatin cytotoxicity by sulphasalazine British Journal of Cancer. 70: 190-194. PMID 7914420 DOI: 10.1038/Bjc.1994.278 |
0.728 |
|
1994 |
Awasthi S, Singhal SS, Srivastava SK, Zimniak P, Bajpai KK, Saxena M, Sharma R, Ziller SA, Frenkel EP, Singh SV. Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. The Journal of Clinical Investigation. 93: 958-65. PMID 7907606 DOI: 10.1172/Jci117102 |
0.735 |
|
1994 |
Awasthi S, Singhal SS, Srivastava SK, Awasthi YC. Doxorubicin, daunorubicin and vinblastine are transported by a glutathione conjugate transporter Anti-Cancer Drugs. 5: 6. DOI: 10.1097/00001813-199409001-00009 |
0.708 |
|
1994 |
Chaubey M, Singhal SS, Awasthi S, Saxena M, Dyer RB, Awasthi YC, Herzog NK. Gender-related differences in expression of murine glutathione S-transferases and their induction by butylated hydroxyanisole Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology. 108: 311-319. DOI: 10.1016/0742-8413(94)00025-6 |
0.686 |
|
1993 |
Singhal SS, Saxena M, Awasthi S, Mukhtar H, Zaidi SI, Ahmad H, Awasthi YC. Glutathione S-transferases of human skin: qualitative and quantitative differences in men and women. Biochimica Et Biophysica Acta. 1163: 266-72. PMID 8507665 DOI: 10.1016/0167-4838(93)90161-J |
0.681 |
|
1993 |
Awasthi S, Singhal SS, Srivastava SK, Awasthi YC. Purification and Characterization of Glutathione S-Transferase of Murine Ovary and Testis Archives of Biochemistry and Biophysics. 301: 143-150. PMID 8442656 DOI: 10.1006/Abbi.1993.1126 |
0.702 |
|
1992 |
Singhal SS, Saxena M, Ahmad H, Awasthi S, Haque AK, Awasthi YC. Glutathione S-transferases of human lung: Characterization and evaluation of the protective role of the α-class isozymes against lipid peroxidation Archives of Biochemistry and Biophysics. 299: 232-241. PMID 1444461 DOI: 10.1016/0003-9861(92)90269-3 |
0.694 |
|
1992 |
Singhal SS, Saxena M, Awasthi S, Ahmad H, Sharma R, Awasthi YC. Gender related differences in the expression and characteristics of glutathione S-transferases of human colon Bba - Gene Structure and Expression. 1171: 19-26. PMID 1420361 DOI: 10.1016/0167-4781(92)90135-M |
0.679 |
|
1992 |
Saxena M, Singhal SS, Awasthi S, Singh SV, Labelle EF, Zimniak P, Awasthi YC. Dinitrophenyl S-glutathione ATPase purified from human muscle catalyzes ATP hydrolysis in the presence of leukotrienes. Archives of Biochemistry and Biophysics. 298: 231-7. PMID 1388012 DOI: 10.1016/0003-9861(92)90117-F |
0.694 |
|
Show low-probability matches. |